v. 11 n. 3 (2020)

Visualizar v. 11 n. 3 (2020)

Publicado: 2020-09-30

Editorial

The headache and adverse events due to the use of personal protective equipment to combat Covid-19

Erlene Roberta Ribeiro dos Santos (Autor)

55-56
- PDF (English)
- HTML (English)

Revisão

The role of TRPM8 in the pathophysiology of migraine

Eduardo de Almeida Guimarães Nogueira, Yara Dadalti Fragoso (Autor)

57-60
- PDF (English)
- HTML (English)
CGRP: from history to clinical application - A review

Afonso Henrique Aragao, Joel Sanabria Duarte, Daniel Benzecry Almeida, Ricardo Ramina (Autor)

61-67
- PDF (English)
- HTML (English)

Relato de caso

Pseudotumor cerebri secondary to secondary hypoparathyroidism and association to Fahr´s Syndrome: a case report

Patrick Giordanni Gomes Sampaio, Hiago Diniz Maracajá, Francielle Lopes de Araújo Batista, Virgínia Gabriela Nóbrega Figueiredo, Nátalia Meg Adijuto de Melo (Autor)

68-71
- PDF (English)
- HTML (English)

Original

A framework for decision making of migraine treatment with anti- CGRP monoclonal antibodies: a guide for real-world practice and public policies

Reinilza Nunes da Gama, Thaiza Agostini Córdoba de Lima, Iron Dangoni Filho, Mario Fernando Prieto Peres (Autor)

72-76
- PDF (English)
- HTML (English)

Artigo Comentado

Anti-CGRP monoclonal antibodies in chronic cluster headache

Aline Turbino Neves Martins da Costa (Autor)

77
- PDF (English)
- HTML (English)
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans

Fabíola Dach Éckeli (Autor)

78
- PDF (English)
- HTML (English)